Analysis of polycyclic aromatic hydrocarbons in amniotic fluid samples from smokers and nonsmokers

Polycyclic Aromatic Compounds

Volumn 28, Issue 1, 2008, Pages 39-66

  Myers, Steven R ^a   Zamora, Raul ^a   Ali, Yeakub ^a   Cunningham, Christopher R ^a   Wright, Terry ^a   Weeks, Jonathan ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Amniotic fluid; Carcinogens; Polycylclic aromatic hydrocarbons; Pregnancy; Tobacco

Indexed keywords

AROMATIZATION; BIOMOLECULES; CARCINOGENS; NAPHTHALENE; OBSTETRICS; PROTEINS; PYRENE; TOBACCO;

AMNIOTIC FLUID; BENZO(A)PYRENE; BIOLOGICAL SAMPLES; BLOOD PROTEIN; FIRST TRIMESTERS; POLYCYLCLIC AROMATIC HYDROCARBON; PREGNANCY; PROTEIN ADDUCTS; SMOKING HISTORY; TOBACCO SMOKE;

METABOLITES;

EID: 38649129877     PISSN: 10406638     EISSN: 15635333     Source Type: Journal    
DOI: 10.1080/10406630701779434     Document Type: Article

References (181)

1. P.E. Cirla, I. Martinotti, M. Buratti, S. Fustinoni, L. Campo, E. Zito, E. Prandi, O. Longhi, D. Cavallo, and V. Foa, Assessment of exposure to Polycyclic Aromatic Hydrocarbons (PAH) in Italian asphalt workers. J Occup Environ Hyg. 4(Suppl 1) (2007): 87-99.
2. M. Ichiba, Y Ogawa, I. Mohri, T. Kondoh, M. Horita, A. Matsumoto, R. Yoshida, Y Matsumoto, H. Saito, K. Ohba, Z. Yamashita, and K. Tomokuni, Analysis of urinary metabolites of polycyclic aromatic hydrocarbons in incineration workers. J Occup Health 49 (2007): 159-164.
3. M. Wilhelm, G. Eberwein, J. Holzer, D. Gladtke, J. Angerer, B. Marczynski, H. Behrendt, J. Ring, D. Sugiri, and U. Ranft, Influence of industrial, sources on children's health-Hot spot studies in North Rhine Westphalia, Germany. Int J Hyg Environ Health. 210 (2007):591-599.
4. P. Cocco, P.S. Moore, M.G. Ennas, M.G. Tocco, A. Ibba, S. Mattuzzi, M. Meloni, M. Monne, G. Piras, S. Collu, G. Sarta, M. Zucca, A. Scarpa, and C. Flore, Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretion. Ann Epidemiol, 17 (2007):1-8.
5. E. Taioli, R.J. Sram, B. Binkova, I. Kalina, T.A. Popov, S. Garte, and P.B. Farmer, Biomarkers of exposure to carcinogenic PAHs and their relationship with environmental factors. Mutat Res, 620 (2007):16-21.
6. J. Unwin, J. Cocker, E. Scobbie, and H. Chambers, An assessment of occupational exposure to polycyclic aromatic hydrocarbons in the UK. Ann Occup Hyg, 50 (2006):395-403.
7. B. Glaser, A. Dreyer, M. Bock, S. Fiedler, M. Mehring, and T. Heitmann, Source apportionment of organic pollutants of a highway-traffic-influenced urban area in Bayreuth (Germany) using biomarker and stable carbon isotope signatures. Environ Sci Technol, 39 (2005):3911-3917.
8. T. Kanoh, M. Fukuda, H. Onozuka, T. Kinouchi, and Y Ohnishi, Urinary 1hydroxypyrene as a marker of exposure to polycyclic aromatic hydrocarbons in environment. Environ Res, 62 (1993):230-241.
9. P. Georgiadis, M. Stoikidou, J. Topinka, S. Kaila, M. Gioka, K. Katsouyanni, R. Sram, and S.A. Kyrtopoulos, Personal exposures to PM(2.5) and polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke at two locations in Greece. J Expo Anal Environ Epidemiol, 1.1 (2001):169-183.
10. G. Scherer and E. Richter, Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal. Hum Exp Toxicol, 16 (1997):449-459.
11. J.G. Van Rooij, M.M. Veeger, M.M. Bodelier-Bade, P.T. Scheepers and F.J. Jongeneelen, Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1 -hydroxypyrene in urine. Int Arch Occup Environ Health, 66 (1994):55-65.
12. G. Scherer, C. Conze, A.R. Tricker, and F. Adlkofer, Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS). Clin Investig, 70 (1992):352-367.
13. G.N. Wogan, S.S. Hecht, J.S. Felton, A.H. Conney, andL.A. Loeb, Environmental and chemical carcinogenesis. Semin Cancer Biol, 14 (2004):473-486.
14. T. Kuljukka-Rabb, K. Peltonen, S. Isotalo, S. Mikkonen, L. Rantanen and K. Savela, Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methychrysene in ahuman mammary carcinoma cell line (MCF-7). Mutagenesis, 16 (2001):353-358.
15. L.S. Goldstein, E.H. Weyand, S. Safe, M. Steinberg, S.J. CuIp, D.W. Gaylor, FA. Beland, and L.V. Rodriguez, Tumors and DNA adducts in mice exposed to benzo[ajpyrene and coal tars: Implications for risk assessment. Environ Health Perspeet, 106 Suppl 6 (1998): 1325-1330.
16. E. Cavalieri, E. Rogan, and D. Sinha, Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J Cancer Res Clin Oncol, 114 (1988):3-9.
17. H. Kamei, Effect of carcinogenic polycyclic aromatic hydrocarbons on mouse embryonic cells in. culture: Induction of spindle-shaped cells. Toxicology, 17 (1980):39-49.
18. M. Buratti, L. Campo, S. Fustinoni, P.E. Cirla, I. Martinotti, D. Cavallo, and V Foa, Urinary hydroxylated metabolites of polycyclic aromatic hydrocarbons as biomarkers of exposure in asphalt workers. Biomarkers, 12 (2007):221-239.
19. J. Angerer, U. Ewers, and M. Wilhelm, Human biomonitoring: State of the art. Int J Hyg Environ Health, 210 (2007):201-228.
20. R. Singh, R.J. Sram, B. Binkova, I. Kalina, T.A. Popov, T. Georgieva, S. Garte, E. Taioli, and P.B. Farmer, The relationship between biomarkers of oxidative DNA damage, polycyclic aromatic hydrocarbon DNA adducts, antioxidant status and genetic susceptibility following exposure to environmental air pollution in humans. Mutat Res, 620 (2007):83-92.
21. Y Hu, Z. Zhou, X. Xue, X. Li, J. Fu, B. Cohen, A.A. Melikian, M. Desai, M.S. Tang, X. Huang, N. Roy, J. Sun, P. Nan, and Q. Qu, Sensitive biomarker of polycyclic aromatic hydrocarbons (PAHs): Urinary 1-hydroxyprene glucuronide in relation to smoking and low ambient levels of exposure. Biomarkers, 11 (2006):306-318.
22. R.B. Gunier, P. Reynolds, S.E.Hurley, S. Yerabati,A. Hertz, P. Strickland, and P.L. Horn-Ross, Estimating exposure to polycyclic aromatic hydrocarbons: A comparison of survey, biological monitoring, and geographic information system-based methods. Cancer Epidemiol Biomarkers Prev, 15 (2006):1376-1381.
23. L. Campo, L. Addario, M. Buratti, L. Scibetta, O. Longhi, C. Valla, P.E. Cirla, I. Martinotti, V. Foa, and S. Fustinoni, Biological monitoring of exposure to polycyclic aromatic hydrocarbons by determination of unmetabolized compounds in urine. Toxicol Lett, 162 (2006):132-138.
24. J.Y Kim, S.S. Hecht, S. Mukherjee, S.G. Carmella, E.G. Rodrigues, and D.C. Christiani, A urinary metabolite of phenanthrene as a biomarker of polycyclic aromatic hydrocarbon metabolic activation in workers exposed to residual oil fly ash. Cancer Epidemiol Biomarkers Prev, 14 (2005):687-692.
25. F.P. Perera, D. Tang, Y.H. Tu, L.A. Cruz, M. Borjas, T. Bernert, and R.M. Whyatt, Biomarkers in maternal and newborn, blood indicate heightened fetal susceptibility. to procarcinogenic DNA damage. Environ Health Perspect, 112 (2004): 1133-1136.
26. M. Sorensen, H. Autrup, P. Moller, O. Hertel, S.S. Jensen, P. Vinzents, L.E. Knudsen and S. Loft, Linking exposure to environmental, pollutants with, biological effects. Mutat Res, 544 (2003):255-271.
27. J. Jacob and A. Seidel, Biomonitoring of polycyclic aromatic hydrocarbons in human urine. J Chromatogr B Analyt Technol Biomed Life Sci, 778 (2002):31-47.
28. S.S. Hecht, Carcinogen biomarkers for lung or oral cancer chemoprevention trials. IARC Sci Publ, 154 (2001):245-255.
29. R.M. Whyatt, W. Jedrychowski, K. Hemminki, R.M. Santella, W.Y Tsai, K. Yang and F.P. Perera, Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol Biomarkers Prev, 10 (2001):581-588.
30. B. Chen, Y Hu, L. Zheng, Q. Wang, Y Zhou and T. Jin, Urinary 1-hydroxypyrene concentrations in Chinese coke oven workers relative to job category, respirator usage, and cigarette smoking. Am J Ind Med.
31. L. Campo, S. Fustinoni, M. Buratti, P.E. Cirla, I. Martinotti and V. Foa (2007) Unmetabolized polycyclic aromatic hydrocarbons in urine as biomarkers of low exposure in asphalt workers. J Occup Environ Hyg, 4 Suppl 1 (2007): 100-110.
32. M.S. Lee, K.D. Eum, K.D. Zoh, T.S. Kim, Y.S. Pak and D. Paek, 1-Hydroxypyrene as a biomarker of PAH exposure among subjects living in two separate regions from a steel mill. Int Arch Occup Environ Health, 80 (2007):671-678.
33. W. Huang, S.P. Caudill, J. Grainger, L.L. Needham and D.G. Patterson, Jr., Levels of 1-hydroxypyrene and other monohydroxy polycyclic aromatic hydrocarbons in children: A study based, on U.S. reference range values. Toxicol Lett, 163 (2006): 10-19.
34. M. Lafontaine, C. Champmartin, P. Simon, P. Delsaut and C. Funck-Brentano, 3-Hydroxybenzo[a]pyrene in the urine of smokers and non-smokers. Toxicol Lett, 162(2006):181-185.
35. M.D. McClean, R.D. Rinehart, L. Ngo, E.A. Eisen, K.T. Kelsey, J.K. Wiencke and R.F. Herrick, Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann Occup Hyg, 48 (2004):565-578.
36. G. Fillmann, G.M. Watson, M. Howsam, E. Francioni, M.H. Depledge, and J.W Readman, Urinary PAH metabolites as biomarkers of exposure in aquatic environments. Environ Sci Technol, 38 (2004):2649-2656.
37. C. Viau, A. Diakite, A. Ruzgyte, B. Tuchweber, C. Blais, M. Bouchard, and A. Vyskocil, Is 1-hydroxypyrene a reliable bioindicator of measured dietary polycyclic aromatic hydrocarbon under normal conditions? J Chromatogr B Analyt Technol Biomed Life Sci, 778 (2002): 165-177.
38. F.J. Jongeneelen, Benchmark guideline for urinary 1 -hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann Occup Hyg, 45 (2001):3-13.
39. W. Huang, T.J. Smith, L. Ngo, T. Wang, H. Chen, F. Wu, R.F. Herrick, D.C. Christiani, and H. Ding, Characterizing and biological monitoring of polycyclic aromatic hydrocarbons in exposures to diesel, exhaust. Environ Sci Technol, 41 (2007):2711-2716.
40. P. Jacob, 3rd, M. Wilson and N.L. Benowitz, Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem, 79, 587-598.
41. J.W. Wegener, G.H. Hopman-Ubbels and M. Van Velzen (2006) Improved glucuronide hydrolysis in the determination of urinary 1-hydroxypyrene. J Chromatogr A, 1134 (2007):232-235.
42. P.L. Lu, M.L. Chen, and I.F. Mao, Urinary 1-hydroxypyrene levels in workers exposed to coke oven emissions at various locations in a coke oven, plant. Arch Environ Health, 57 (2002):255-261.
43. S.S. Hecht, Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer. Carcinogenesis, 23 (2002):907-922.
44. J.D. Adams, Jr., H. Yagi, W. Levin, and D.M. Jerina, Stereo-selectivity and regioselectivity in the metabolism of 7,8-dihydrobenzo[a]pyrene by cytochrome P450, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats. Chem Biol Interact, 95 (1995):57-77.
45. W.M. Baird, R. Chemerys, J.B. Grinspan, S.N. Mueller, and E.M. Levine, Benzo(a)pyrene metabolism in bovine aortic endothelial and bovine lung fibroblast-like cell cultures. Cancer Res, 40 (1980):1781-1786.
46. A.M. Batt, P. MacKenzie, O. Hanninen, and H. Vainio, Glucuronidation of 3hydroxybenzo(a)pyrene in liver microsomes. Med Biol, 57 (1979):281-286.
47. J. DiGiovanni, D.R. Miller, J.M. Singer, A. Viaje, and T.J. Slaga, Benzo(a)-pyrene metabolism in primary cultures of mouse epidermal cells and untransformed and transformed epidermal, cell lines. Cancer Res, 42 (1982):2579-2586.
48. H. Glatt, A. Seidel, O. Ribeiro, C. Kirkby, P. Hirom, and F. Oesch, Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8- dihydrobenzo[a]-pyrene, a secondary metabolite of benzo[ajpyrene. Carcinogenesis, 8 (1987):1621-1627.
49. D. Pruess-Schwartz and W.M. Baird, Benzo(a)pyrene:DNA adduct formation in early-passage Wistar rat embryo cell cultures: Evidence for multiple pathways of activation of benzo(a)pyrene. Cancer Res, 46 (1986):545-552.
50. H. Wang, X.B. Yang, A.L. Liu, H.Y Zhen, L. Guo, H.S. Liang, Y.Y Bi, Y Bai, Y.W. Chen, and T.C. Wu, Significant positive correlation of plasma BPDE-albumin adducts to urinary 1-hydroxypyrene in coke oven workers. Biomed Environ Sci, 20 (2007): 179-183.
51. K. Forster, R. Preuss, B. Rossbach, T. Bruning, J. Angerer, and P. Simon, 3Hydroxybenzo[a]pyrene in the urine of workers with occupational exposure to polycyclic aromatic hydrocarbons in different industries. Occup Environ Med. (2007). http://oem.bmj.com/cgi/con.tent/abstract/oem.2006.030809v1
52. A.M. Hansen, O. Raaschou-Nielsen, and L.E. Knudsen (2005)Urinary 1-hydroxypyrene in children living in city and rural residences in Denmark. Sci Total Environ, 347 (2007):98-105.
53. P.J. Tsai, T.S. Shih, H.L. Chen, W.J. Lee, C.H. Lai, and S.H. Liou, Urinary 1hydroxypyrene as an indicator for assessing the exposures of booth, attendants of a highway toll station, to polycyclic aromatic hydrocarbons. Environ Sci Technol, 38 (2004):56-61.
54. A.M. Hansen, H. Wallin, M.L. Binderup, M. Dybdahl, H. Autrup, S. Loft, and L.E. Knudsen, Urinary 1 -hydroxypyrene and mutagenicity in bus drivers and mail carriers exposed to urban air pollution in. Denmark. Mutat Res, 557 (2004):7-17.
55. F.P. Perera, V. Rauh, R.M. Whyatt, W.Y. Tsai, D. Tang, D. Diaz, L. Hoepner, D. Barr, Y.H. Tu, D. Camann, and P. Kinney, Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect, 114 (2006): 1287-1292.
56. W. Jedrychowski, R.M. Whyatt, D.E. Camann, U.V. Bawle, K. Peki, J.D. Spengler, T.S. Dumyahn, A. Penar, and F.F. Perera, Effect of prenatal PAH exposure on birth outcomes and neurocognitive development in a cohort of newborns in Poland. Study design and preliminary ambient data. Int J Occup Med Environ Health, 16 (2003):21-29.
57. F.P. Perera, W. Jedrychowski, V. Rauh, and R.M. Whyatt, Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect, 107 Suppl 3 (1999):451-460.
58. P. Sartorelli, S. Sartorelli, N. Bozzi, D. Orsi, and A. Cenni, [Urinary 1hydroxypyrene in full-term pregnant women and their newborn babies as an index of biological exposure to polycyclic aromatic hydrocarbons]. Minerva Med, 85 (1994):307-311.
59. S.D. Holladay and B.J. Smith, Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene. Environ Res, 68 (1995): 106-113.
60. E. Conover, Hazardous exposures during pregnancy. J Obstet Gynecol Neonatal Nurs, 23 (1994):524-532.
61. C. Hansen, L.D. Sorensen, I. Asmussen, and H. Autrup, Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratog Carcinog Mutagen, 12 (1992):51-60.
62. D.R. Goodman, R.C. James, and R.D. Harbison, Placental toxicology. Food Chem Toxicol, 20 (1982): 123-128.
63. C. Hansen, I. Asmussen, and H. Autrup, Detection of carcinogen-DNA adducts in human fetal tissues by the 32P-postlabeling procedure. Environ Health Perspect, 99(1993):229-231.
64. A. Castonguay, H. Tjalve, N. Trushin, and S.S. Hecht, Perinatal metabolism of the tobacco-specific carcinogen. 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in C57BL mice. J Natl Cancer Inst, 72 (1984): 117-1126.
65. S. Farkas, J. Hussein, R.E. Ariano, D.S. Sitar, and S.U. Hasan, Prenatal cigarette smoke exposure: Pregnancy outcome and gestational changes in plasma nicotine concentration, hematocrit, and carboxyhemoglobin in a newly standardized rat model. Toxicol Appl Pharmacol, 214 (2006):118-125.
66. J. Lumley, S.S. Oliver, C. Chamberlain, and L. Oakley, Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev, CD001055.
67. K.C. Lodrup Carlsen, J.J. Jaakkola, P. Nafstad, and K.H. Carlsen, In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J, 10 (1997): 1774-1779.
68. D.S. Lambers and K.E. Clark, The maternal and fetal physiologic effects of nicotine. Semin Perinatol, 20 (1996): 115-126.
69. J.R. Villalbi, J. Salvador, G. Cano-Serral, M.C. Rodriguez-Sanz, and C. Borrell, Maternal smoking, social class and outcomes of pregnancy. Paediatr Perinat Epidemiol, 21 (2007):441-447.
70. M.D. Cornelius, L. Goldschmidt, N. DeGenna, and N.L. Day, Smoking during teenage pregnancies: Effects on behavioral problems in offspring. Nicotine Tob Res, 9 (2007):739-750.
71. J.D. Meeker, S.A. Missmer, D.W. Cramer, and R. Hauser, Maternal exposure to second-hand tobacco smoke and pregnancy outcome among couples undergoing assisted reproduction. Hum Reprod, 22 (2007):337-345.
72. P. Schuetze, and R.D. Eiden, The association between maternal smoking and secondhand exposure and autonomic functioning at 2-4 weeks of age. Infant BehavDev, 29 (2006):32-43.
73. S. Pattenden, T. Antova, M. Neuberger, B. Nikiforov, M. De Sario, L. Grize, J. Heinrich, F. Hruba, N. Janssen, H. Luttmann-Gibson, L. Privalova, P. Rudnai, A. Splichalova, R. Zlotkowska, and T. Fletcher, Parental smoking and children's respiratory health: Independent effects of prenatal, and postnatal, exposure. Tob Control, 15 (2006):294-301.
74. S. Deacon, Maternal smoking during pregnancy is associated with a higher risk of non-syndromic orofacial clefts in infants. Evid Based Dent, 6 (2005):43-44.
75. H.S. Bada, A. Das, CR. Bauer, S. Shankaran, B.M.Lester, C.C. Gard, L.L.Wright, L. Lagasse, and R. Higgins, Low birth weight and preterm births: Etiologic fraction attributable to prenatal drug exposure. J Perinatol, 25 (2005):631-637.
76. M.E. Zotti, W.H. Replogle, and W.M. Sappenfield, Prenatal smoking and birth outcomes among Mississippi residents. J Miss State Med Assoc, 44 (2003):3-9.
77. A. Bouckaert, Smoking during pregnancy: Foetal growth retardation and other risks for the newborn. Stat Med, 19 (2000):239-254.
78. M.L. Lindbohm, M. Sallmen, and H. Taskinen, Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health, 28 Suppl 2 (2002):84-96.
79. R.L. Andres and M.C. Day, Perinatal, complications associated with maternal tobacco use. Semin Neonatol, 5 (2000):231-241.
80. K. Haug, L.M. Irgens, R. Skjaerven, T. Markestad, V Baste, and P. Schreuder, Maternal smoking and birthweight: Effect modification of period, maternal age and paternal, smoking. Acta Obstet Gynecol Scand, 79 (2000):485-489.
81. E. Nelson, C. Goubet-Wiemers, Y. Guo, and K. Jodscheit, Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: Histological changes. Hum Exp Toxicol, 18 (1999):257-264.
82. G.A. Ellard, F.D. Johnstone, R.J. Prescott, W. Ji-Xian, and M. Jian-Hua, Smoking during pregnancy: The dose dependence of birthweight deficits. Br J Obstet Gynaecol, 103 (1996):806-813.
83. E. Petridou, D. Trichopoulos, K. Revinthi, D. Tong, and E. Papathoma, Modulation of birthweight through gestational age and fetal growth. Child Care Health Dev, 22 (1996):37-53.
84. L.G. Spector, S.S. Hecht, S. Ognjanovic, S.G. Carmella, and J.A. Ross, Detection of cotinine in newborn, dried blood spots. Cancer Epidemiol Biomarkers Prev, 16 (2007): 1902-1905.
85. C.S. Buhimschi, I.A. Buhimschi, S. Abdel-Razeq, V.A. Rosenberg, S.F. Thung, G. Zhao, E. Wang, and V. Bhandari, Proteomic biomarkers of intra-amniotic inflammation: Relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res, 61 (2007):318-324.
86. M.G. Gravett, A. Thomas, K.A. Schneider, A.P. Reddy, S. Dasari, T. Jacob, X. Lu, M. Rodland, L. Pereira, D.W. Sadowsky, C.T. Roberts, Jr., M.J. Novy, and S.R. Nagalla, Proteomic analysis of cervical-vaginal, fluid: Identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res, 6 (2007): 89-96.
87. I. Vogel, P. Thorsen, A. Curry, P. Sandager, and N. Uldbjerg, Biomarkers for the prediction, of preterm delivery. Acta Obstet Gynecol Scand, 84 (2005):516-525.
88. F.P. Perera, R.M. Whyatt, W. Jedrychowski, V. Rauh, D. Manchester, R.M. Santella, and R. Ottman, Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol, 147 (1998):309-314.
89. M.A. Norman, E.A. Holly, D.K. Ahn, S. Preston-Martin, B.A. Mueller, and P.M. Bracci, Prenatal, exposure to tobacco smoke and childhood brain tumors: Results from the United States West Coast childhood brain tumor study. Cancer Epidemiol Biomarkers Prev, 5 (1996): 127-133.
90. H. Autrup, Transplacental transfer of genotoxins and transplacental carcinogenesis. Environ Health Perspect, 101 Suppl 2, 33-38.
91. J.L. Mumford, X. Lee, J. Lewtas, T.L. Young, and R.M. Santelia (1993) DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal, combustion emissions and high lung cancer mortality. Environ Health Perspect, 99 (1993):83-87.
92. D.B. Barr, A. Bishop, and L.L. Needham, Concentrations of xenobiotic chemicals in the maternal-fetal, unit. Reprod Toxicol, 23 (2007):260-266.
93. T. Gray and M. Huestis, Bioanalytical procedures for monitoring in utero drug exposure. AnalBioanal Chem, 388 (2007): 1455-1465.
94. E. Kohler, S. Avenarais, A. Rabsilber, C. Gerloff, and G. Jorch, Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium. Hum Exp Toxicol, 26 (2007):535-544.
95. R.K. Ojha, S.K. Singh, S. Batra, V. Sreenivas, andJ.M. Puliyel, Lactate: Creatinine ratio in babies with thin meconium, staining of amniotic fluid. BMC Pediatr, 6, 13.
96. G. Ventolini, R. Neiger, D. Hood, and C. Beicastro, Update on assessment of fetal lung maturity. J Obstet Gynaecol, 25 (2005), 535-538.
97. B.Y. Liu, C.C. Wang, T.K. Lau, C.Y. Chu, M. Phil, C.P. Pang, M.S. Rogers, and T.N. Leung, Meconium-stained liquor during labor is associated with raised neonatal cord blood 8-iso-prostaglandin F2alpha concentration. Am J Obstet Gynecol, 192 (2005):289-294.
98. D. Wessels, D.B. Barr, and P. Mendola, Use of biomarkers to indicate exposure of children to organophosphate pesticides: Implications for a longitudinal, study of children's environmental health. EnvironHealth Perspect, 111 (2003):1939-1946.
99. G. Koren, D. Chan, J. Klein, and T. Karaskov, Estimation of fetal exposure to drugs of abuse, environmental tobacco smoke, and ethanol. Ther Drug Monit, 24 (2002):23-25.
100. F.P. Perera, D. Tang, V. Rauh, K. Lester, W.Y Tsai, Y.H. Tu, L. Weiss, L. Hoepner, J. King, G. Del Priore, and S.A. Lederman, Relationships among polycyclic aromatic hydrocarbon-DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environ Health Perspect, 113 (2005): 1062-1067.
101. M. Chelchowska, and T. Laskowska-Klita, Effect of maternal smoking on some markers of iron status in umbilical cord blood. Rocz Akad Med Bialymst, 47 (2002):235-240.
102. X.M. Shen, C.H. Yan, D. Guo, S.M. Wu, R.Q. Li, H. Huang, L.M. Ao, J.D. Zhou, Z.Y Hong, J.D. Xu, X.M. Jin, and J.M. Tang, Umbilical cord blood lead levels in Shanghai, China. Biomed Environ Sci, 10 (1997):38-46.
103. S. Hu, J.A. Loo, and D.T. Wong, Human body fluid proteome analysis. Proteomics, 6 (2006): 6326-6353.
104. R. Mukhopadhyay, Biomarkers for preterm birth. J Proteome Res, 4 (2005), 1900.
105. A. Petzold, D. Stiefel, and A.J. Copp, Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental, myelomeningocele. J. Neurochern, 95 (2005):594-598.
106. J.A. Martin, B.E. Hamilton, P.D. Sutton, S.J. Ventura, F. Menacker, and M.L. Munson, Births: Final, data for 2003. Natl Vital Stat Rep, 54 (2005): 1-116.
107. J.P. Lerner, Fetal, growth, and well-being. Obstet Gynecol Clin North Am, 31 (2004): 159-176.
108. E.F. Magann and J.N. Martin, Jr., Amniotic fluid volume assessment in singleton and twin pregnancies. Obstet Gynecol Clin North Am, 26 (1999):579-593.
109. D. Ogunyemi, S. Hullett, J. Leeper, and A. Risk, Prepregnancy body mass index, weight gain during pregnancy, and perinatal outcome in a rural black population. J Matern Fetal Med, 7 (1998): 190-193.
110. S.D. Harrast and H.J. Kalkwarf, Effects of gestational age, maternal diabetes, and intrauterine growth retardation on markers of fetal, bone turnover in amniotic fluid. Calcif Tissue Int, 62 (1998):205-208.
111. K. Haram, E. Softeland, and R. Bukowski, Intrauterine growth restriction. Int J Gynaecol Obstet, 93 (2006):5-12.
112. G. Grange, C. Vayssiere, A. Borgne, A. Ouazana, J.P. L'Huillier, P. Valensi, G. Peiffer, H.J. Aubin, D. Renon, D. Thomas and F. Lebargy, Description of tobacco addiction in pregnant women. Eur J Obstet Gynecol ReprodBiol, 120 (2005): 146-151.
113. G.J. Mizejewski, Physiology of alpha-fetoprotein as a biomarker for perinatal distress: Relevance to adverse pregnancy outcome. Exp Biol Med (Maywood), 232 (2007):993-1004.
114. S.P. Chauhan, M. Taylor, D. Shields, D. Parker, J.A. Scardo, and E.F. Magann, Intrauterine growth restriction and oligohydramnios among high-risk patients. Am J Perinatol, 24 (2007):215-221.
115. B.Bromley, T. D. Shipp, and B. Benacerraf, Assessment of the third-trimester fetus using 3-dimensional volumes: A pilot study. J. Clin Ultrasound, 35 (2007):231237.
116. M.G. Margariti, A.K. Tsakalof, and A.M. Tsatsakis, Analytical methods of biological monitoring for exposure to pesticides: Recent, update. Ther Drug Monit, 29(2007):150-163.
117. A. O'Shea and S. Eappen, Amniotic fluid embolism. Int Anesthesiol Clin, 45 (2007): 17-28.
118. M. Alberry and P. Soothill, Management, of fetal growth restriction. Arch Dis Child Fetal Neonatal Ed, 92, F62-67.
119. F.G. Krupa, D. Faltin, J.G. Cecatti, F.G. Surita, and J.P. Souza Predictors of preterm birth. Int J Gynaecol Obstet, 94 (2006), 5-11.
120. R.L. Goldenberg, A.R. Goepfert, and P.S. Ramsey, Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol, 192 (2005), S36-46.
121. M.A. Underwood, W.M. Gilbert, and M.P. Sherman, Amniotic fluid: Not. just fetal, urine anymore. J Perinatol, 25 (2005), (2007):341-348.
122. E. Jauniaux and B. Gulbis, Fluid compartments of the embryonic environment. Hum Reprod Update, 6 (2000):268-278.
123. R.D. Wilson, Amniocentesis and chorionic villus sampling. Curr Opin Obstet Gynecol, 12 (2000):81-86.
124. D.A. Calhoun, S.N. Murthy, B.G. Bryant, S.A. Luedtke, and V. Bhatt-Mehta, Recent advances in neonatal pharmacotherapy. Ann Pharmacother, 40 (2006):710-719.
125. P. Malcus, Antenatal fetal surveillance. Curr Opin Obstet Gynecol, 16 (2004): 123-128.
126. G.J. Hofmeyr and A.M. Gulmezoglu, Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume. Cochrane Database Syst Rev, CD000134.
127. G.J. Hofmeyr and A.M. Gulmezoglu, Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal, amniotic fluid volume. Cochrane Database Syst Rev, CD000134 (2000).
128. P.C. Santiago-Munoz, D.D. McIntire, R.G. Barber, S.M. Megison, D.M. Twickler, and J.S. Dashe Outcomes of pregnancies with fetal gastroschisis. Obstet Gynecol, 110 (2007):663-668.
129. K. O'Donoghue, L. Giorgi, V. Pontello, L. Pasquim, and S. Kumar, Amniocentesis in the third trimester of pregnancy. Prenat Diagn. (2000)
130. S. Tharmaratnam Fetal distress. Baillieres Best Praet Res Clin Obstet Gynaecol, 14 (2000): 155-172.
131. R.L. Skovgaard and A.L. Silvonek, Oligohydramnios. Literature review and case study. J Nurse Midwifery, 38 (1993):208-215.
132. E.M. Wintour and L. Shandley, Effects of fetal fluid balance on amniotic fluid volume. Semin Perinatol, 17 (1993): 158-172.
133. P.M. Doubilet and C.B. Benson, Fetal, growth disturbances. Semin Roentgenol, 25 (1990):309-316.
134. O.O. Ogunkeye and J.A. Otubu, Tests of foetal lung maturity: A review. Afr J Med Med Sci, 19 (1990):65-70.
135. C.V. Smith, Amniotic fluid assessment. Obstet Gynecol Clin North Am, 17 (1990): 187-200.
136. K.F. Widlund and T. Gottvall, Routine assessment of amniotic fluid alphaFetoprotein in early second-trimester amniocentesis is no longer justified. Acta Obstet Gynecol Scand, 86 (2007):167-171.
137. M.F. Delisle and R.D. Wilson, First trimester prenatal, diagnosis: Amniocentesis. Semin Perinatol, 23 (1999):414-423.
138. T.R. Moore, Clinical assessment of amniotic fluid. Clin Obstet Gynecol, 40 (1997):303-313.
139. S. Smidt-Jensen and K. Sundberg, Early amniocentesis. Curr Opin Obstet Gynecol, 7 (1995):117-121.
140. K. Sundberg, F.S. Jorgensen, A. Tabor, and J. Bang, Experience with early amniocentesis. JPerinat Med, 23 (1995):149-158.
141. K. Steyn, T. de Wet, Y Saloojee, H. Nel, and D. Yach, The influence of maternal cigarette smoking, snuff use and passive smoking on pregnancy outcomes: The Birth To Ten Study. Paediatr Perinat Epidemiol, 20 (2006):90-99.
142. J. Kalinka, W. Hanke, and W. Sobala, Impact of prenatal tobacco smoke exposure, as measured by midgestation serum cotinine levels, on fetal biometry and umbilical flow velocity waveforms. Am J Perinatol, 22 (2005):41-47.
143. D. Hruba and P. Kachlik, Influence of maternal, active and passive smoking during pregnancy on, birthweight in newborns. Cent Eur J Public Health, 8 (2000):249-252.
144. J. Lumley, S. Oliver, and E. Waters, Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev, CD001055 (2000).
145. R. Hebert What's new in nicotine & tobacco research? Nicotine Tob Res, 9 (2007): 627-630.
146. S. Kurtoglu, T. Gunes, E. Koklu, O. Bastug, O. Canoz, M. Kula, F Bastug, and I. Gunes, Influence of maternal nicotine exposure on neonatal, rat bone: Protective effect of pentoxifylline. Exp Biol Med (Maywood), 232 (2007):398-405.
147. T. Bajanowski, B. Brinkmann, E.A. Mitchell, M.M. Vennemann, H.W. Leukel, K.P. Larsch, and J. Beike, Nicotine and cotinine in infants dying from sudden infant, death syndrome. Int J Legal Med. (2007)
148. S.A. Bainbridge and G.N. Smith The effect of nicotine on in vitro placental, perfusion pressure. Can J Physiol Pharmacol, 84 (2006):953-957.
149. W Hanke, W. Sobala, and J. Kalinka, [The effect of environmental tobacco smoke on birthweight: A prospective study employing biomarkers of exposure]. Ginekol Pol, 71 (2000):833-836.
150. G.C. Windham, A. Eaton, and B. Hopkins, Evidence for an association between environmental tobacco smoke exposure and birthweight: A meta-analysis and new data. Paediatr Perinat Epidemiol, 13 (1999):35-57.
151. E. Florek, W Piekoszewski, W. Lechowicz, A. Szymanska, and M.K. Kornacka, [Determination of 4-(methylnirosamino) -4-(3-pyridyl)-l-butanol (NNA) in urine of pregnant women by means of LC/MS/MS], Przegl Lek, 63 (2006):926-931.
152. M. Chaaya, S. Jabbour, Z. El-Roueiheb, and H. Chemaitelly, Knowledge, attitudes, and practices of argileh (water pipe or hubble-bubble) and cigarette smoking among pregnant women in Lebanon. Addict Behav, 29 (2004): 1821-1831.
153. N. Lelong, M. Kaminski, M.J. Saurel-Cubizolies, and M.H. Bouvier-Colle, Postpartum, return, to smoking among usual smokers who quit during pregnancy. Eur J Public Health, 11 (2001):334-339.
154. S.H. Ebrahim,R.L.Floyd,R.K. Merritt, 2nd,P. Decoufle, andD. Holtzman, Trends in pregnancy-related smoking rates in the United States, 1987-1996. Jama, 283 (2000):361-366.
155. J.M. Siegfried, Lung cancer screening in high-risk populations. Clin Lung Cancer, 1 (1997), 100-106; discussion 107.
156. J.E. Fielding (1987) Smoking and women: Tragedy of the majority. N Engl J Med, 317(1999):1343-1345.
157. R.M. Kretzschmar, Smoking and health: The role of the obstetrician and gynecologist. Obstet Gynecol, 55 (1980):403-406.
158. D.S. Crowley and M. Geary, Passive smoking in pregnancy. BMJ, 316 (1998): 1981-1982.
159. M.A. Honein, S.A. Rasmussen, J. Reefhuis, P.A. Romitti, E.J. Lammer, L. Sun, and A. Correa, Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial, clefts. Epidemiology, 18 (2007):226-233.
160. D.K. Eaton, L. Kann, S. Kinchen, J. Ross, J. Hawkins, W.A. Harris, R. Lowry, T. McManus, D. Chyen, S. Shanklin, C. Lim, J.A. Grunbaum, and H. Wechsler, Youth risk behavior surveillance-United States, 2005. MMWR Surveill Summ, 55 (2006): 1-108.
161. J.M. Pachlopnik Schmid, C.E. Kuehni, M.P. Strippoli, H.L. Roiha, R. Pavlovic, P. Latzin, S. Gallati, R. Kraemer, C Dahinden, and U. Frey, Maternal tobacco smoking and decreased leukocytes, including dendritic cells, in neonates. Pediatr Res, 6.1 (2007):462-466.
162. A.P. Key, M. Ferguson, D.L. Molfese, K. Peach, C. Lehman, and V.J. Molfese, Smoking during pregnancy affects speech-processing ability in newborn infants. Environ Health Perspect, 115 (2007): 623-629.
163. A.L.Penn,R.L.Rouse, D.W. Horohov, M.T. Kearney, D.B.Paulsen, andL.Lomax, In utero exposure to environmental tobacco smoke potentiates adult responses to allergen in BALB/c mice. Environ Health Perspect, 115 (2007):548-555.
164. P.S. Noakes, R. Thomas, C. Lane, TA. Mori, A.E. Barden, S.G. Devadason, and S.L. Prescott, Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax, 62 (2007):714-717.
165. J.B. Berz, A.S. Carter, R.L. Wagmiller, S.M. Horwitz, K.K. Murdock, and M. Briggs-Gowan, Prevalence and correlates of early onset asthma and wheezing in a healthy birth cohort, of 2- to 3-year olds. J Pediatr Psychol, 32 (2007): 154-166.
166. E.A. Mitchell and J. Milerad, Smoking and the sudden infant death syndrome. Rev Environ Health, 21 (2006):81-103.
167. L. George, F. Granath, A.L. Johansson, G. Anneren, and S. Cnattingius, Environmental tobacco smoke and risk of spontaneous abortion. Epidemiology, 17 (2006):500-505.
168. K.N. Ramesh, M.K. Vidyadaran, Y.M. Goh, A.A. Nasaruddin, A.B. Jammal, and S. Zainab, Maternal passive smoking and its effect on maternal, neonatal, and placental parameters. Med J Malaysia, 60 (2005):305-310.
169. S. Shankaran, A. Das, CR. Bauer, H. Bada, B. Lester, L. Wright, R. Higgins, and K. Poole, Fetal origin of childhood disease: Intrauterine growth restriction in term infants and risk for hypertension, at 6 years of age. Arch Pediatr Adolesc Med, 160 (2006), 977-981.
170. D.P. Misra and R.H. Nguyen Environmental tobacco smoke and low birth weight: A.hazard in the workplace? Environ Health Perspect, 107 Suppl 6 (1999): 897-904.
171. J. Dejmek, S .G. Selevan, I. Ben.es, I. Solansky, and R.J. Sram, Fetal, growth, and maternal exposure to particulate matter during pregnancy. Environ Health Perspect, 107 (1999):475-480.
172. J. Leger, C. Limoni, and P. Czernichow, Prediction of the outcome of growth at 2 years of age in neonates with intra-uterine growth retardation. Early Hum Dev, 48 (1997):211-223.
173. B.L. Horta, CG. Victora, A.M. Menezes, R. Halpern, and F.C. Barros, Low birthweight, preterm births and intrauterine growth retardation in relation, to maternal smoking. Paediatr Perinat Epidemiol, 11 (1997):140-151.
174. B. Chen, L.X. Zheng, and Q.Y Wnag, [Monitoring result of content of urine 1-hydroxypyrene of workers in coke screening workshop of coking plants], Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 25 (2007):289-290.
175. B. Chen, Y Hu, T. Jin, L. Zheng, Q. Wang, Y. Shen, and Y. Zhou, Higher urinary 1-hydroxypyrene concentration is associated with cooking practice in a Chinese population. Toxicol Lett, 171 (2007):119-125.
176. T. Kawamoto, M. Yang, Y.D. Kim, H. Kim, T. Oyama, T. Isse, K. Matsuno, T. Katoh, and I. Uchiyama, Effects of lifestyle on urinary 1-hydroxypyrene concentration. J. Occup Health, 49 (2007): 183-189.
177. M.D. McClean, R.D. Rinehart, A. Sapkota, J.M. Cavallari, and R.F. Herrick, Dermal, exposure and urinary 1-hydroxypyrene among asphalt roofing workers. J Occup Environ Hyg, 4 Suppl, 1 (2007):118-126.
178. B. Chen, Y Hu, T. Jin, D. Lu, M. Shao, L. Zheng, Q. Wang, Y. Shen, H. Liu, Y Liu, and Y Zhou, The influence of metabolic gene polymorphisms on urinary 1 -hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ, 381 (2007):38-46.
179. C.Y. Chuang and C.C. Chang, Urinary 1-hydroxypyrene level relative to vehicle exhaust exposure mediated by metabolic enzyme polymorphisms. J. Occup Health, 49(2007):140-151.
180. W Zhang, D. Xu, G. Zhuang, C. Ding, G. Wang, J. Chang, and G. Ren, A Pilot Study on Using Urinary 1-Hydroxypyrene Biomarker for Exposure to PAHs in Beijing. Environ Monit Assess, 131 (2007):387-394.
181. A.P. Mucha, D. Hryhorczuk, A. Serdyuk, J. Nakonechny, A. Zvinchuk, S. Erdal, M. Caudill, P. Scheff, E. Lukyanova, Z. Shkiryak-Nyzhnyk, and N. Chislovska, Urinary 1 -hydroxypyrene as a biomarker of PAH exposure in 3-year-old Ukrainian children. Environ Health Perspect, 114 (2006):603-609.